
Those registered to attend the Expert Panels 2019 in personal are:
Ali TURHAN Professor, Inserm/ ISPSIRIUS- INGESTEM Amanda Mack Director, iPSC Reprogramming Technologies Fujifilm CDI
Anders Aspegren GMP Manufacturing Manager Takara Bio Europe
Andras Dinnyes Director BioTalentum Ltd
Andreas Kurtz Work Group Lead/ Director/ Porfessor GAiT/ hPSCReg / Charite
Andres Bratt-Leal VP of R&D Aspen Neuroscience
Anna Falk Associate Professor Karolinska Institutet
Annelise Griscelli Bennaceur Professor, Inserm/ ISPSIRIUS- INGESTEM ASHRAF EL FIKY MEDICAL OFFICER EMMES
Brad Hamilton CSO LifeVault Bio
Camie Chan Chief Operating Officer Novoheart
Catharina Brandsten Director R&D Takara Bio Europe
Claudia Raggi Founder Morphocell Technologies
Deborah Hursh Senior Investigator CBER/FDA
Derek Hei SVP Manufacturing, Quality, and Regulatory BlueRock Therapeutics
Don Paul Kovarcik Sr. Product Manager Thermo Fisher Scientific
Eihachiro Kawase Junior Associate Professor Institute for Frontier Life and Medical Sciences, Kyoto University
Elizabeth Schwarzbach Chief Business Officer NYSCF
Elsa Abranches Director, UK Stem Cell Bank NIBSC, MHRA
Fanyi Zeng
Fumiya Ohashi Researcher Terumo
Glyn Stacey CEO ISCBI Interantional Stem Cell Banking Initiative
HIDETAKA OHARA Director Sumitomo Dainippon Pharma
Hiroki Ozawa Manager, Regenerative Medicine Ajinomoto Health & Nutrition North America
HISAKO HASHIMOTO Dupty Director R&D Center for Cell Therapy, Foundation for Biomedical Research and Innovation
Howard Federoff Distinguished Professor of Neurology UCI
Howard Kim Senior Director, Cell Therapy Programs NYSCF
Jane Lebkowski
Jihwan Song Director/Professor GAiT/CHA University
Jiwu WANG Allele Biotechnologies
Jo Mountford Head of Cellular Therapeutics SNBTS
John DE VOS Head of Cell Processing Facility University Hospital of Montpellier, INSERM, France
Joseph Gold Sr. Dir., Manufacturing City of Hope
Kei Takada Chief of CPF Inst. for frontier life and medical Scienses, Kyoto University
Ken Kono Chief, Section of Viral Safety, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Kristina Runeberg Site Head Takara Bio Europe AB
Lise Munsie Development Manager CCRM
Marcel Frankowiack Team Leader Sales Biolamina
Martha Lundberg Program Director NIH-NHLBI
Massimiliano Paganelli Founder & Chief Technology Officer Morphocell Technologies
Mathilde GIRARD Innovation and development manager in cell therapy YposKesi
Mehrnaz Ghazvini manager of ips core facility Erasmus Medical Center
Micha Drukker Group leader Helmholtz Institute Munich
Michael Sheldon RUDRC
Miho Furue (Kusuda) Senior Fellow NIKON Corporation
Noriko Santo Deputy Manager, Division of Regenerative Medicine Research, Department of Research Promortion Japan Agency for Medical Research and Development
Norio Hashimoto General Manager Nissan Chemical America Corporation
Patricia Pranke Full Professor UFRGS
Paul Dougall Product Manager Bio-Techne
Philip Manos President/Scientific Director EverCell Bio
Rachel Steeg Project Manager Fraunhofer UK
Rafal Krol Researcher, Facility for iPS Cell Therapy, R&D Unit Kyoto University, CiRA
Rajesh Ambasudhan Allele Biotechnologies
Rhishikesh Bargaje Scientist Orig3n
Ronald Li Director/ CEO/ Professor GAiT/ Novoheart / Hong Kong University
Ross Okamura CIRM
Rumi Sawada Chief, Section of Tissue-Engineered Products, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Shaji Velayudhan Principal Investigator Centre for Stem Cell Research
Sharon Bahia Operational and Business Transition Manager Public Helath England
Shekhar Jha Scientific & Regulatory Manager National Institutes of Health
Shinichi Nakano Staff Healios K.K.
Stephen Lin Scientific Officer CIRM
Stephen Sullivan International Liaison Officer GAiT
Steve OH Institute Prof. BTI, A*STAR
Takafusa Hikichi QC manager / Researcher Kyoto-Univ.
Takamasa Hirai Visiting Research Scientist, Section of Viral Safety, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Takashi Nakamura Project Manager Healios K.K.
Takumi Miura Chief, Section of Somatic Cell Therapy Products, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Takuya Kuroda Senior Research Scientist, Section of Pluripotent Stem Cell-Derived Products, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Tenneille Ludwig Wicell
Thorsten Gorba Translating Center Director IQVIA CAGT Center
Wataru Fujibuchi Professor Kyoto University
Wen Bo Wang Senior VP Technical Operations Fate Tx
Ying Chen PHD student iPS center, Kyoto University
Yoji Sato Head, Division of Cell-Based Therapeutic Products Japan National Institute of Health Sciences
Yuya Yokozawa Manager, Technical Consulting Group Veritas Corporation